Infectious complications and immunotherapy: old pitfalls and new horizons

Angioletta Lasagna; Irene Cassaniti; Paolo Sacchi; Fausto Baldanti; Raffaele Bruno; Paolo Pedrazzoli

doi:10.2217/fon-2022-0277

Infectious complications and immunotherapy: old pitfalls and new horizons

Future Oncol. 2022 Jul;18(22):2377-2381. doi: 10.2217/fon-2022-0277. Epub 2022 Jun 9.

Authors

Angioletta Lasagna¹, Irene Cassaniti², Paolo Sacchi³, Fausto Baldanti^{2

4}, Raffaele Bruno^{3

4}, Paolo Pedrazzoli^{1

5}

Affiliations

¹ Medical Oncology Unit, Fondazione IRCCS Policlinico San Matteo, Viale Camillo Golgi 19, Pavia, 27100, Italy.
² Microbiology & Virology Department, Fondazione IRCCS Policlinico San Matteo, Viale Camillo Golgi 19, Pavia, 27100, Italy.
³ Division of Infectious Diseases I, Fondazione IRCCS Policlinico San Matteo, Viale Camillo Golgi 19, Pavia, 27100, Italy.
⁴ Department of Clinical Surgical Diagnostic & Pediatric Sciences, University of Pavia, Viale Camillo Golgi 19, Pavia, 27100, Italy.
⁵ Department of Internal Medicine & Medical Therapy, University of Pavia, Viale Camillo Golgi 19, Pavia, 27100, Italy.

PMID: 35678614
DOI: 10.2217/fon-2022-0277

No abstract available

Keywords: IRIS; immune checkpoint inhibitors; immune exhaustion; immune reconstitution inflammatory syndrome; immune-related adverse effects; infectious complications; virome.

Publication types

Editorial

MeSH terms

Humans
Immunologic Factors*
Immunotherapy* / adverse effects

Substances

Immunologic Factors